title: Comment on "A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome" by Guillaume Pineton de Chambrun et al. [Digestive and Liver Disease 2015;47:119-24].
authors: Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK. Electronic address: jamesquinn@doctors.org.uk.
authors: James A
authors: JA
authors: Quinn
authors: Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK; Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK.
authors: Alexander C
authors: AC
authors: Ford
mesh_terms: D015746:Abdominal Pain / Q000628:therapy*; D005260:Female; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000628:therapy*; D008297:Male; D019936:Probiotics / Q000627:therapeutic use*; D012441:Saccharomyces cerevisiae